Introduction SPCs are national rights provided for by EU regulations. The European Commission published a proposal for a new Regulation on 28 May 2018 to amend Regulation (EC) No469/2009 concerning the SPC for medicinal products. Further details of the proposal can be...
Reassuringly, the draft Withdrawal Agreement explicitly addresses Intellectual Property and pleasingly confirms that the European Union is prepared to agree to continuous protection in the UK, by way of a corresponding UK right, for owners of an EU trade mark or a...
Extending the patent term for such high value patented products can be particularly significant for rights holders even when the additional term is mere days. A supplementary protection certificate is intended to partially compensate a patent holder for the patent...
Europe The Enlarged Board of Appeal in G 02/08 clarified that second medical use claims to new and inventive dosage regimes are patentable, even where the substance or composition, and the disease to be treated, are the same as in the prior art. Nevertheless, the...
At the beginning of 2017 the Preparatory Committee of the Unified Patent Court thought that it would be likely that the systems of the UPC would begin provisional operation before summer 2017 in advance of the UPC agreement coming into force later that year. It...
Recent Comments